Abbott gets USFDA emergency use authorization for COVID-19 molecular test Medical Dialogues Bureau20 March 2020 10:15 AM ISTThe Abbott m2000 RealTime System is a molecular solution featuring a broad menu of tests, including ones for infectious diseases.
Roche begins Phase III clinical trial of Actemra in hospitalised patients with severe COVID-19 pneumonia Medical Dialogues Bureau20 March 2020 10:00 AM ISTBasel: Roche has announced that it is working with the Food & Drug Administration (FDA) to initiate a randomised, double-blind, placebo-controlled...
NPPA, regularly monitoring situations of prices and availability of essentials medicines, says Minister Medical Dialogues Bureau19 March 2020 3:15 PM ISTDelhi: The Minister for Chemicals & Fertilizers Shri. D.V. Sadananda Gowda informed the Lok Sabha in written reply today that NPPA is...
Lilly Receives FDA Breakthrough Therapy Designation for Baricitinib for Alopecia Areata Medical Dialogues Bureau19 March 2020 12:56 PM ISTBaricitinib is currently approved for the treatment of adults with moderately to severely active rheumatoid arthritis (RA).
Cipla joins hands with CSIR-IICT to develop coronavirus drug Medical Dialogues Bureau19 March 2020 12:10 PM ISTHyderabad: Hyderabad-based CSIR-Indian Institute of Chemical Technology (IICT) has tied up with pharmaceutical giant Cipla to work on the...
Pfizer, Biontech join hands to co-develop mRNA-based coronavirus vaccine Medical Dialogues Bureau19 March 2020 11:00 AM ISTNew York & Mainz: Pfizer Inc.and BioNTech SE has announced that the companies have agreed to a letter of intent regarding the co-development and...
Emami share buyback size likely to be Rs 900-1000 crore Medical Dialogues Bureau19 March 2020 9:00 AM ISTKolkata: The size of proposed buyback of shares by Emami Ltd is likely to be in the range of Rs 900-1,000 crore, sources said on Monday. The promoters...
Regeneron, Sanofi begin testing use of Arthritis Drug Kevzara to treat COVID-19 Medical Dialogues Bureau18 March 2020 12:24 PM ISTKevzara is a fully-human monoclonal antibody that inhibits the interleukin-6 (IL-6) pathway by binding and blocking the IL-6 receptor.The use of...
Alembic Pharma gets USFDA EIR for API Facility at Karakhadi Medical Dialogues Bureau18 March 2020 12:00 PM ISTGujrat: Alembic Pharmaceuticals Limited has announced that it has received Establishment Inspection Report (EIR) from US Food and Drug Administration...
Dr Reddy's Labs launches Ziprasidone Mesylate for Injection in US Market Medical Dialogues Bureau18 March 2020 10:00 AM ISTHyderabad and Princeton: Dr Reddy's Laboratories Ltd. has announced the launch of Ziprasidone Mesylate for Injection, 20 mg (base)/mL Single-dose...
Novacyt gets British orders for coronavirus testing product Medical Dialogues Bureau18 March 2020 9:00 AM ISTParis and Camberley: Novacyt, an international specialist in clinical diagnostics, has provided an update regarding the novel coronavirus (COVID-19)...
National Arogya Fair held from 12 th to 16 th February 2020 Medical Dialogues Bureau18 March 2020 9:00 AM ISTDehradun: PhD Chamber in association with Ministry of AYUSH, Government of India & Government of Uttarakhand organized National 'Arogya Fair' held...
